HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

Inhibition of PD-L1 using drug MPDL3280A for patients with metastatic urothelial bladder cancer

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia

Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers

ASCO 2014 roundup